| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 78.71 | 0.41 (+0.52%) | 57.26 - 87.46 | 129.9 thousand (Below Avg) |
Market data as of 4:03PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 78.39 |
|---|---|
| Previous Close | 78.30 |
| Day's Range | 77.94 - 78.95 |
| Market Cap | 3.2B |
| Avg Volume (10 Day) | 242.9K |
| Price/Earnings (Trailing 12 Mo.) | 27.0x |
| Earnings Per Share (Trailing 12 Mo.) | 2.91 |
| Dividend Yield | 0.34 (1.73%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Teleflex Announces Launch of its Next Generation Vascular Positioning System®
Business Wire - Monday 05/20/2013 5:00 PM ET
Teleflex to Focus on Arrow® Advanced Interventional Radiology Portfolio at EuroPCR
Business Wire - Thursday 05/16/2013 5:00 PM ET
Teleflex to Present at the Deutsche Bank 38th Annual Health Care Conference
Business Wire - Wednesday 05/15/2013 7:00 AM ET
Teleflex to Focus on Managing Humidification, One Patient At A Time Campaign at FOCUS 2013 Spring Conference
Business Wire - Thursday 05/09/2013 7:00 AM ET
Teleflex Announces Quarterly Dividend
Business Wire - Friday 05/03/2013 5:00 PM ET
Teleflex® to Show Enhanced Line of Pain Management Solutions at 38th Annual ASRA Regional Anesthesia and Acute Pain Medicine Meeting
Business Wire - Tuesday 04/30/2013 5:30 PM ET
Teleflex to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Business Wire - Tuesday 04/30/2013 5:00 PM ET
Teleflex Reports First Quarter 2013 Results
Business Wire - Tuesday 04/30/2013 7:00 AM ET
| TFX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 1.26% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.55 | |
| LT Debt/Equity | 0.55 | |
| Earnings Yield | 3.70% | |
| Price/Sales | 2.05 |
| Company | Last | Change |
|---|---|---|
| West Pharmaceutical Services Inc | 67.38 | -0.34% |
| Hill-Rom Holdings Inc | 35.83 | -0.39% |
| Haemonetics Corp | 41.08 | -0.48% |
| Thoratec Corp | 31.39 | -0.41% |
| Mindray Medical International Ltd | 41.05 | +0.07% |
Data is delayed by at least 15 min.